Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 255 publications
Utility of Circulating Tumor DNA as a Monitoring Tool for Marker-Negative Germ Cell Tumors and Somatic Type Malignancies.
Journal: Clinical genitourinary cancer
Published: July 02, 2026
D-VRD vs. D-KRD induction in transplant-eligible multiple myeloma: a real-world comparison.
Journal: Leukemia & lymphoma
Published: June 26, 2026
Recent advances in bispecific natural killer cell engagers for cancer immunotherapy.
Journal: Immunotherapy
Published: June 19, 2026
A Simplified Frailty Score Predicts Outcomes in Newly Diagnosed Multiple Myeloma Patients Undergoing Upfront Autologous Hematopoietic Stem Cell Transplantation.
Journal: Transplantation and cellular therapy
Published: May 18, 2026
Prognostic impact of monosomy 13 and deletion of 13q in multiple myeloma patients undergoing upfront autologous transplantation.
Journal: British journal of haematology
Published: May 14, 2026
Divergent biology and outcomes of somatic transformations in germ cell tumors.
Journal: The oncologist
Published: April 20, 2026
Randomized Trial of Two Fractionation Schedules of Myeloablative Busulfan with Fludarabine and Cladribine in Acute Myeloid Leukemia or Myelodysplastic Syndromes.
Journal: Transplantation and cellular therapy
Published: March 26, 2026
Carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) induction prior to autologous haematopoietic stem cell transplant/transplantation in newly diagnosed multiple myeloma.
Journal: British journal of haematology
Published: March 13, 2026
The Pitfalls of Categorizing Donor Age: Arbitrary Cutoffs Fail to Predict Survival in Haploidentical HCT.
Journal: American journal of hematology
Published: February 27, 2026
D-VRD induction and autologous transplant in patients ≥70 years.
Journal: Blood cancer journal
Published: February 12, 2026
Last Updated: 09/26/2026